Azithromycin use and outcomes in patients with COVID-19: an observational real-world study

Ippazio Cosimo Antonazzo,Carla Fornari,Davide Rozza,Sara Conti,Raffaella di Pasquale,Paolo Cortesi,Shaniko Kaleci,Pietro Ferrara,Alberto Zucchi,Giovanni Maifredi,Andrea Silenzi,Giancarlo Cesana,Lorenzo Giovanni Mantovani,Giampiero Mazzaglia

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases（2022）

引用 3|浏览21

暂无评分

摘要

•The beneficial effect of azithromycin in patients with COVID-19 is debated•Azithromycin was associated with a 1.5-fold higher risk of hospitalization in patients with COVID-19•Results did not indicate any significant risk reduction in the other studied outcomes•Results raise concerns on risks associated with inappropriate use of azithromycin

查看译文

关键词

Azithromycin,COVID-19,Hospitalization,Intensive care unit access,Mechanical ventilation,Mortality,Italy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要